...
首页> 外文期刊>RSC Advances >Novel rhodanines with anticancer activity: design, synthesis and CoMSIA study
【24h】

Novel rhodanines with anticancer activity: design, synthesis and CoMSIA study

机译:具有抗癌活性的新型罗丹丹:设计,合成和CoMSIA研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Three different series of some novel N-substituted rhodanines were designed for anticancer activity and prepared from the corresponding dithiocarbamates. The synthesized compounds were analyzed by IR, NMR and MASS to confirm their structures. All the titled compounds were found to be of Z configuration based on NMR spectral analysis. All the synthesized rhodanines were screened for in vitro anticancer activity against MCF-7 breast cancer cells at the concentration of 10 mu g. The compounds showed moderate to significant cytotoxicity. Amongst them, interestingly, compounds 10, 22 and 33 with cinnamoyl substitution at the 5th position of the thiazolidine ring system showed significant activity. Further, we subjected all these compounds to a CoMSIA study to study their 3D quantitative structure activity relationships (3D QSAR). The illustration about the design of novel rhodanines, synthesis, analysis, activity against MCF-7 cells and SAR via CoMSIA study are reported here.
机译:设计了三种不同系列的一些新颖的N-取代的罗丹宁类药物以用于抗癌活性,并由相应的二硫代氨基甲酸酯制备。通过IR,NMR和MASS分析合成的化合物以确认其结构。根据NMR光谱分析发现所有标题化合物均为Z构型。筛选所有合成的罗丹酮,以10μg的浓度对MCF-7乳腺癌细胞进行体外抗癌活性。该化合物显示出中度至明显的细胞毒性。其中,有趣的是,在噻唑烷环系统第5位具有肉桂酰基取代基的化合物10、22和33显示出显着的活性。此外,我们对所有这些化合物进行了CoMSIA研究,以研究其3D定量结构活性关系(3D QSAR)。通过CoMSIA研究报告了有关新型罗丹宁的设计,合成,分析,针对MCF-7细胞和SAR的活性的插图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号